U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H22ClN3O2.ClH
Molecular Weight 360.279
Optical Activity ( + / - )
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RENZAPRIDE HYDROCHLORIDE

SMILES

Cl.COC1=CC(N)=C(Cl)C=C1C(=O)N[C@@H]2CC[N@@]3CCC[C@H]2C3

InChI

InChIKey=WYONTPMGUQWRKN-WUCQATPYSA-N
InChI=1S/C16H22ClN3O2.ClH/c1-22-15-8-13(18)12(17)7-11(15)16(21)19-14-4-6-20-5-2-3-10(14)9-20;/h7-8,10,14H,2-6,9,18H2,1H3,(H,19,21);1H/t10?,14-;/m1./s1

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C16H22ClN3O2
Molecular Weight 323.818
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Renzapride (BRL-24924) is a mixed 5-hydroxytryptamine type 4 (5-HT4) agonist and 5-HT3 receptor antagonist. This compound has a stimulatory effect on gastrointestinal motility and transit. Renzapride has been evaluated for use in treatment of irritable bowel syndrome (IBS). Data also suggested a potentially beneficial effect on abdominal pain/discomfort in women with constipation-predominant irritable bowel syndrome. Phase III clinical trials investigated if this drug could help alleviate the symptoms associated with this type of IBS. However, one phase III study has been terminated due to inefficient efficacy (compared to placebo).

Approval Year

PubMed

PubMed

TitleDatePubMed
Cloning, expression and pharmacology of the mouse 5-HT(4L) receptor.
1996 Nov 25
[3H]RS 57639, a high affinity, selective 5-HT4 receptor partial agonist, specifically labels guinea-pig striatal and rat cloned (5-HT4S and 5-HT4L) receptors.
1997 Apr-May
Cloning and expression of human 5-HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclase.
1997 Oct 20
Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus.
1998 Jun
Substance Class Chemical
Created
by admin
on Sat Dec 16 05:30:57 UTC 2023
Edited
by admin
on Sat Dec 16 05:30:57 UTC 2023
Record UNII
6H0SNK4GNT
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RENZAPRIDE HYDROCHLORIDE
Common Name English
BENZAMIDE, 4-AMINO-N-(1R,4S,5R)-1-AZABICYCLO(3.3.1)NON-4-YL-5-CHLORO-2-METHOXY-, HYDROCHLORIDE (1:1), REL-
Common Name English
BENZAMIDE, 4-AMINO-N-1-AZABICYCLO(3.3.1)NON-4-YL-5-CHLORO-2-METHOXY-, MONOHYDROCHLORIDE, ENDO-(±)-
Common Name English
BRL-24924
Code English
Code System Code Type Description
SMS_ID
300000001440
Created by admin on Sat Dec 16 05:30:57 UTC 2023 , Edited by admin on Sat Dec 16 05:30:57 UTC 2023
PRIMARY
EPA CompTox
DTXSID40911383
Created by admin on Sat Dec 16 05:30:57 UTC 2023 , Edited by admin on Sat Dec 16 05:30:57 UTC 2023
PRIMARY
CAS
109872-41-5
Created by admin on Sat Dec 16 05:30:57 UTC 2023 , Edited by admin on Sat Dec 16 05:30:57 UTC 2023
PRIMARY
PUBCHEM
20843171
Created by admin on Sat Dec 16 05:30:57 UTC 2023 , Edited by admin on Sat Dec 16 05:30:57 UTC 2023
PRIMARY
FDA UNII
6H0SNK4GNT
Created by admin on Sat Dec 16 05:30:57 UTC 2023 , Edited by admin on Sat Dec 16 05:30:57 UTC 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY